Page last updated: 2024-08-24

triazoles and Pancreatitis

triazoles has been researched along with Pancreatitis in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (21.43)	18.2507
2000's	8 (19.05)	29.6817
2010's	24 (57.14)	24.3611
2020's	1 (2.38)	2.80

Authors

Authors	Studies
Aprile, S; Bhela, IP; Cordero-Sanchez, C; Cuzzocrea, S; Di Paola, R; Fusco, R; Genazzani, AA; Pirali, T; Purghè, B; Riva, B; Serafini, M	1
Alansary, D; Aprile, S; Biocotino, I; Canonico, PL; Cordero-Sanchez, C; Cuzzocrea, S; Di Paola, R; Galli, U; Genazzani, AA; Griglio, A; Grosa, G; Gugliandolo, E; Lim, D; Niemeyer, B; Pirali, T; Riva, B; Serafini, M; Sorba, G	1
Chang, HY; Clark, JM; Richards, TM; Segal, JB; Singh, S; Weiner, JP	1
Gale, EA	1
Cohen, D	2
Drake, AJ; Iyer, SN; Mendez, CE; Tanenberg, RJ; West, RL	1
Aston-Mourney, K; Goldstein, LC; Hull, RL; Meier, DT; Samarasekera, T; Subramanian, SL; Zraika, S	1
Harja, E; Lord, J; Skyler, JS	1
Rouse, R; Stewart, S; Xu, L; Zhang, J	1
Duke, J; Li, X; Zhang, Z	1
Nandith, A; Ramachandran, A; Shetty, AS; Snehalath, C	1
Coignard-Biehler, H; Jullien, V; Lanternier, F; Lortholary, O; Pilmis, B; Rouzaud, C	1
Leal, AS; Liby, KT; Pioli, PA; Royce, DB; Sporn, MB; Williams, CR	1
Bloechle, C; Izbicki, JR; Kaifi, J; Kluth, D; Mann, O; Schneider, C; Strate, T; Tiefenbacher, WJ; Yekebas, E	1
Chen, C; Chen, H; Li, XH; Xia, SH	1
Arnold Chan, K; Dore, DD; Seeger, JD	1
Clay, RJ; Engel, SS; Goldstein, BJ; Golm, GT; Kaufman, KD; Machotka, SV; Williams-Herman, DE	1
Garg, R; Hussey, C; Ibrahim, S	1
Chen, W; Garg, R; Pendergrass, M	1
Butler, PC; Elashoff, M; Elashoff, R; Gier, B; Matveyenko, AV	1
Hawkes, N	1
Gundert-Remy, U; Spranger, J; Stammschulte, T	1
Niessen, M; Spinas, GA; Xu, L	1
Masmiquel Comas, L; Nicolau Ramis, J	1
Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P	1
Bate, A; Hägg, S; Spigset, O	1
Kujath, P; Scheele, J	1
Biskup, W; Celiński, K; Cichoz-Lach, H; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M	1
Jancar, S; Machado, MC; Molan, NA; Shio, MT; Souza, LJ	1
Abdo, EE; Bonizzia, A; Coelho, AM; Jancar, S; Kwasniewski, FH; Machado, MC; Sampietre, SN	1
Levine, BA; Olson, MS; Zhou, W	1
Fomochkin, II	1
Fomochkin, II; Kolbasin, PN	1
Fomochkin, II; Kazakova, VV; Kolbasin, PN	1
Li, J; Li, N; Tu, W; Zhu, W	1
Iwahisa, Y; Okamoto, H; Terasawa, M	1
Creutzfeldt, W; Fayyazzi, A; Leonhardt, U; Seidensticker, F; Söling, HD; Stöckmann, F	1
Levine, BA; McCollum, MO; Olson, MS; Zhou, W	1
Chao, W; Levine, BA; Olson, MS; Zhou, WG	1

Reviews

3 review(s) available for triazoles and Pancreatitis

Article	Year
Therapy for acute pancreatitis with platelet-activating factor receptor antagonists. World journal of gastroenterology, 2008, Aug-14, Volume: 14, Issue:30 Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Azepines; Ginkgolides; Humans; Imidazoles; Lactones; Leucine; Pancreatitis; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Tetrahydroisoquinolines; Treatment Outcome; Triazoles	2008
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. International journal of clinical practice, 2010, Volume: 64, Issue:7 Topics: Acute Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Pancreatitis; Pyrazines; Randomized Controlled Trials as Topic; Risk Factors; Sitagliptin Phosphate; Triazoles	2010
[Clinical effectiveness of trental and thiotriazolinum in the treatment of acute pancreatitis]. Klinichna khirurhiia, 1999, Issue:10 Topics: Acute Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Pancreatitis; Pentoxifylline; Treatment Outcome; Triazoles	1999

Other Studies

39 other study(ies) available for triazoles and Pancreatitis

Article	Year
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors. Journal of medicinal chemistry, 2020, 12-10, Volume: 63, Issue:23 Topics: Animals; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Cell Line; Dihydroorotate Dehydrogenase; Drug Discovery; Drug Stability; Enzyme Inhibitors; Humans; Male; Mice, Inbred C57BL; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Pancreatitis; Solubility; Structure-Activity Relationship; Triazoles	2020
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis. Journal of medicinal chemistry, 2018, 11-08, Volume: 61, Issue:21 Topics: Acute Disease; Animals; Biological Transport; Calcium; Drug Design; Endoplasmic Reticulum; HEK293 Cells; Humans; Mice; Pancreatitis; Triazoles	2018
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA internal medicine, 2013, Apr-08, Volume: 173, Issue:7 Topics: Acute Disease; Adolescent; Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide 1; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms	2013
GLP-1 based agents and acute pancreatitis : drug safety falls victim to the three monkey paradigm. BMJ (Clinical research ed.), 2013, Feb-27, Volume: 346 Topics: Acute Disease; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Metaphor; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms	2013
Two drugs for type 2 diabetes seem to raise risk of acute pancreatitis, study shows. BMJ (Clinical research ed.), 2013, Feb-27, Volume: 346 Topics: Acute Disease; Animals; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Exenatide; Humans; Hypoglycemic Agents; Pancreatitis; Peptides; Pyrazines; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms	2013
Pancreatitis associated with incretin-based therapies. Diabetes care, 2013, Volume: 36, Issue:4 Topics: Diabetes Mellitus, Type 2; Exenatide; Humans; Hypoglycemic Agents; Incretins; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms	2013
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds. BMJ (Clinical research ed.), 2013, Apr-23, Volume: 346 Topics: Adamantane; Diabetes Mellitus; Dipeptides; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Linagliptin; Pancreatitis; Purines; Pyrazines; Quinazolines; Sitagliptin Phosphate; Triazoles; United States	2013
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. American journal of physiology. Endocrinology and metabolism, 2013, Aug-15, Volume: 305, Issue:4 Topics: Animals; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Hemizygote; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Male; Metformin; Mice; Mice, Transgenic; Pancreas; Pancreatic Neoplasms; Pancreatitis; Plaque, Amyloid; Pyrazines; Random Allocation; Recombinant Proteins; Sitagliptin Phosphate; Time Factors; Triazoles	2013
An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology. Diabetes technology & therapeutics, 2013, Volume: 15, Issue:8 Topics: Adolescent; Adult; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hyperplasia; Hypoglycemic Agents; Incretins; Male; Middle Aged; Models, Statistical; Pancreas; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Tissue Banks; Triazoles; Venoms; Young Adult	2013
High fat diet and GLP-1 drugs induce pancreatic injury in mice. Toxicology and applied pharmacology, 2014, Apr-15, Volume: 276, Issue:2 Topics: Acute Disease; Animals; Apoptosis; Atrophy; Diet, High-Fat; Exenatide; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Necrosis; Pancreas; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Triazoles; Venoms	2014
Glucagon-like peptide 1-based therapies and risk of pancreatitis: a self-controlled case series analysis. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:3 Topics: Adult; Aged; Cohort Studies; Databases, Factual; Exenatide; Female; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Factors; Sitagliptin Phosphate; Triazoles; Venoms; Young Adult	2014
Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes. The Journal of the Association of Physicians of India, 2013, Volume: 61, Issue:8 Topics: Adult; Aged; Amylases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipase; Male; Middle Aged; Pancreatitis; Pyrazines; Retrospective Studies; Risk Assessment; Sitagliptin Phosphate; Triazoles	2013
Acute reversible pancreatitis induced by posaconazole. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2 Topics: Acute Disease; Antifungal Agents; Female; Humans; Leukemia, Myeloid, Acute; Lipase; Mycoses; Pancreatitis; Triazoles	2017
Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer letters, 2017, 05-28, Volume: 394 Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Azepines; Benzodiazepines; Cell Line, Tumor; Cell Proliferation; Ceruletide; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Inflammation Mediators; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Pancreatic Neoplasms; Pancreatitis; Phosphorylation; Proto-Oncogene Proteins c-myc; RAW 264.7 Cells; Signal Transduction; Triazoles	2017
Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity. Pancreas, 2009, Volume: 38, Issue:1 Topics: Amylases; Animals; Azepines; Capillaries; Cell Adhesion; Ceruletide; Disease Models, Animal; Edema; Female; Glycodeoxycholic Acid; Leukocytes; Microcirculation; Oligopeptides; Pancreas; Pancreatitis; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Regional Blood Flow; Severity of Illness Index; Taurocholic Acid; Time Factors; Triazoles	2009
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide. Current medical research and opinion, 2009, Volume: 25, Issue:4 Topics: Adolescent; Adult; Databases, Factual; Exenatide; Female; Glyburide; Humans; Hypoglycemic Agents; Insurance, Health; Male; Metformin; Middle Aged; Pancreatitis; Peptides; Pyrazines; Risk Assessment; Safety; Sitagliptin Phosphate; Triazoles; United States; Venoms; Young Adult	2009
Pancreatitis associated with the use of sitagliptin and orlistat combination: a case report. Diabetic medicine : a journal of the British Diabetic Association, 2010, Volume: 27, Issue:4 Topics: Anti-Obesity Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Lactones; Middle Aged; Orlistat; Pancreatitis; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles	2010
Sitagliptin: too many cases of pancreatitis. Prescrire international, 2010, Volume: 19, Issue:106 Topics: Acute Disease; Humans; Hypoglycemic Agents; Pancreatitis; Pyrazines; Sitagliptin Phosphate; Triazoles	2010
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes care, 2010, Volume: 33, Issue:11 Topics: Diabetes Mellitus, Type 2; Exenatide; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pancreatitis; Peptides; Proportional Hazards Models; Pyrazines; Retrospective Studies; Sitagliptin Phosphate; Triazoles; Venoms	2010
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology, 2011, Volume: 141, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Odds Ratio; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Thyroid Neoplasms; Triazoles; United States; United States Food and Drug Administration; Venoms	2011
Journal withdraws article after complaints from drug manufacturers. BMJ (Clinical research ed.), 2011, Apr-11, Volume: 342 Topics: Diabetes Mellitus, Type 2; Drug Industry; Editorial Policies; Exenatide; Humans; Hypoglycemic Agents; Incretins; Pancreatitis; Peptides; Periodicals as Topic; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms	2011
GLP-1-based therapies: the dilemma of uncertainty. Gastroenterology, 2011, Volume: 141, Issue:1 Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Risk Assessment; Risk Factors; Sitagliptin Phosphate; Thyroid Neoplasms; Triazoles; Uncertainty; Venoms	2011
Pro- or anti-inflammatory properties of the adipokine dipeptidyl peptidase-4? Gastroenterology, 2011, Volume: 141, Issue:6 Topics: Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Receptors, Glucagon; Thyroid Neoplasms; Triazoles; Venoms	2011
Exenatide and sitagliptin: pancreatitis and pancreatic cancer. Harms on the rise. Prescrire international, 2011, Volume: 20, Issue:121 Topics: Exenatide; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms	2011
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Animals; Breast Neoplasms; Calcitonin; Carcinoma, Medullary; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Disease Susceptibility; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infections; Liraglutide; Pancreatitis; Pharmacovigilance; Pioglitazone; Pyrazines; Risk Assessment; Safety-Based Drug Withdrawals; Sitagliptin Phosphate; Species Specificity; Thiazolidinediones; Thyroid Neoplasms; Triazoles; Urinary Bladder Neoplasms	2012
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:5 Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole	2012
Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. International clinical psychopharmacology, 2003, Volume: 18, Issue:3 Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Chemical and Drug Induced Liver Injury; Cyclohexanols; Databases, Factual; Humans; Neural Networks, Computer; Pancreatitis; Piperazines; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride; World Health Organization	2003
Candida peritonitis in a patient with necrotising cholecystitis and pancreatitis. Mycoses, 2006, Volume: 49, Issue:4 Topics: Aged; Aged, 80 and over; Candida albicans; Cholecystitis; Humans; Male; Pancreatitis; Peritonitis; Pyrimidines; Triazoles; Voriconazole	2006
The role of adenosine A2a receptors in experimental acute pancreatitis. Advances in medical sciences, 2006, Volume: 51 Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Amylases; Animals; Disease Models, Animal; Immunohistochemistry; Lipase; Male; Pancreas; Pancreatitis; Phenethylamines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Taurocholic Acid; Triazines; Triazoles	2006
Acute pancreatitis affects non-parenchymal liver cells by a mechanism dependent on platelet-activating factor. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2007, Volume: 7, Issue:1 Topics: Acute Disease; Animals; Azepines; Candida albicans; Kupffer Cells; Lipopolysaccharides; Liver; Male; Nitric Oxide; Pancreatitis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Taurocholic Acid; Triazoles; Tumor Necrosis Factors	2007
Effect of PAF antagonists on cerulein-induced pancreatitis. Journal of lipid mediators and cell signalling, 1995, Volume: 11, Issue:1 Topics: Acute Disease; Amylases; Animals; Azepines; Capillary Permeability; Ceruletide; Diterpenes; Evans Blue; Ginkgolides; Lactones; Male; Pancreas; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles	1995
Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. The American journal of pathology, 1993, Volume: 142, Issue:5 Topics: Animals; Azepines; Calcium; Ceruletide; Male; Osmolar Concentration; Pancreas; Pancreatitis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles	1993
[The effect of trental and thiotriazoline on tissue blood flow, oxygen tension and vascular reactivity in the pancreas in acute experimental pancreatitis]. Klinichna khirurhiia, 1998, Issue:1 Topics: Acute Disease; Animals; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Hemodynamics; Oxygen Consumption; Pancreas; Pancreatitis; Pentoxifylline; Regional Blood Flow; Triazoles; Vasodilator Agents	1998
[Effects of trental and thiotriazoline on neutrophil dehydrogenase activity in acute experimental pancreatitis]. Klinichna khirurhiia, 1998, Issue:3 Topics: Acute Disease; Animals; Dogs; Neutrophils; Oxidoreductases; Pancreatitis; Pentoxifylline; Triazoles; Vasodilator Agents	1998
Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs. Chinese medical journal, 2000, Volume: 113, Issue:8 Topics: Acute Disease; Animals; Azepines; Intestinal Mucosa; Pancreatitis; Platelet Activating Factor; Swine; Triazoles	2000
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor. Agents and actions, 1992, Volume: 35, Issue:3-4 Topics: Animals; Arthus Reaction; Azepines; Capillary Permeability; Disease Models, Animal; Female; Guinea Pigs; Male; Molecular Structure; Ovalbumin; Pancreatitis; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin; Skin Diseases; Triazoles	1992
Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models. International journal of pancreatology : official journal of the International Association of Pancreatology, 1992, Volume: 12, Issue:2 Topics: Animals; Ascites; Azepines; Male; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Survival Rate; Triazoles	1992
Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. The American journal of pathology, 1992, Volume: 140, Issue:4 Topics: Animals; Azepines; Bronchoalveolar Lavage Fluid; Diterpenes; Eicosanoids; Enzymes; Ginkgolides; Lactones; Lung; Pancreatitis; Platelet Activating Factor; Rats; Triazoles	1992
Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat. The American journal of pathology, 1990, Volume: 137, Issue:6 Topics: Amylases; Animals; Azepines; Chronic Disease; Diterpenes; Ginkgolides; Lactones; Ligation; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Time Factors; Triazoles	1990